OtherArticle
Augmented clearance of nivolumab is associated with renal functions in chronic renal disease model rats
Kazuaki Taguchi, Yukitaka Hayashi, Mayu Ohuchi, Hotaka Yamada, Shigehiro Yagishita, Yuki Enoki, Kazuaki Matsumoto and Akinobu Hamada
Drug Metabolism and Disposition August 4, 2021, DMD-AR-2021-000520; DOI: https://doi.org/10.1124/dmd.121.000520
Kazuaki Taguchi
1Keio University, Japan
Yukitaka Hayashi
2Faculty of Pharmacy, Keio University of Pharmacy, Japan
Mayu Ohuchi
3Division of Molecular Pharmacology, National Cancer Center Research Institute., Japan
Hotaka Yamada
2Faculty of Pharmacy, Keio University of Pharmacy, Japan
Shigehiro Yagishita
3Division of Molecular Pharmacology, National Cancer Center Research Institute., Japan
Yuki Enoki
2Faculty of Pharmacy, Keio University of Pharmacy, Japan
Kazuaki Matsumoto
2Faculty of Pharmacy, Keio University of Pharmacy, Japan
Akinobu Hamada
3Division of Molecular Pharmacology, National Cancer Center Research Institute., Japan
Jump to comment:
No eLetters have been published for this article.
In this issue
OtherArticle
Accelerated blood clearance of nivolumab in renal impairment
Kazuaki Taguchi, Yukitaka Hayashi, Mayu Ohuchi, Hotaka Yamada, Shigehiro Yagishita, Yuki Enoki, Kazuaki Matsumoto and Akinobu Hamada
Drug Metabolism and Disposition August 4, 2021, DMD-AR-2021-000520; DOI: https://doi.org/10.1124/dmd.121.000520
OtherArticle
Accelerated blood clearance of nivolumab in renal impairment
Kazuaki Taguchi, Yukitaka Hayashi, Mayu Ohuchi, Hotaka Yamada, Shigehiro Yagishita, Yuki Enoki, Kazuaki Matsumoto and Akinobu Hamada
Drug Metabolism and Disposition August 4, 2021, DMD-AR-2021-000520; DOI: https://doi.org/10.1124/dmd.121.000520
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement